5N2V image
Deposition Date 2017-02-08
Release Date 2017-05-24
Last Version Date 2024-02-28
Entry Detail
PDB ID:
5N2V
Title:
Changes in conformational equilibria regulate the activity of the Dcp2 decapping enzyme
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.10 Å
R-Value Free:
0.28
R-Value Work:
0.23
R-Value Observed:
0.24
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:mRNA-decapping enzyme subunit 1
Gene (Uniprot):dcp1
Chain IDs:A, D
Chain Length:129
Number of Molecules:2
Biological Source:Schizosaccharomyces pombe
Polymer Type:polypeptide(L)
Molecule:mRNA decapping complex subunit 2
Gene (Uniprot):dcp2
Chain IDs:B, E
Chain Length:245
Number of Molecules:2
Biological Source:Schizosaccharomyces pombe
Polymer Type:polypeptide(L)
Molecule:Edc1
Gene (Uniprot):SPAC18G6.09c
Chain IDs:C, F
Chain Length:26
Number of Molecules:2
Biological Source:Schizosaccharomyces pombe
Primary Citation
Changes in conformational equilibria regulate the activity of the Dcp2 decapping enzyme.
Proc. Natl. Acad. Sci. U.S.A. 114 6034 6039 (2017)
PMID: 28533364 DOI: 10.1073/pnas.1704496114

Abstact

Crystal structures of enzymes are indispensable to understanding their mechanisms on a molecular level. It, however, remains challenging to determine which structures are adopted in solution, especially for dynamic complexes. Here, we study the bilobed decapping enzyme Dcp2 that removes the 5' cap structure from eukaryotic mRNA and thereby efficiently terminates gene expression. The numerous Dcp2 structures can be grouped into six states where the domain orientation between the catalytic and regulatory domains significantly differs. Despite this wealth of structural information it is not possible to correlate these states with the catalytic cycle or the activity of the enzyme. Using methyl transverse relaxation-optimized NMR spectroscopy, we demonstrate that only three of the six domain orientations are present in solution, where Dcp2 adopts an open, a closed, or a catalytically active state. We show how mRNA substrate and the activator proteins Dcp1 and Edc1 influence the dynamic equilibria between these states and how this modulates catalytic activity. Importantly, the active state of the complex is only stably formed in the presence of both activators and the mRNA substrate or the m7GDP decapping product, which we rationalize based on a crystal structure of the Dcp1:Dcp2:Edc1:m7GDP complex. Interestingly, we find that the activating mechanisms in Dcp2 also result in a shift of the substrate specificity from bacterial to eukaryotic mRNA.

Legend

Protein

Chemical

Disease

Primary Citation of related structures